JMP Securities Biotechnology Overview Feb 3, 2025 04:43AM
Crinetics (CRNX) PT Raised to $80 at JMP Securities, 'Paltusotine is Faster, Better, and More Convenient' Mar 20, 2024 03:46AM
Crinetics (CRNX) PT Raised to $56 at JMP Securities, 'our top pick into the end of the year' Sep 11, 2023 10:03AM
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference Jun 7, 2022 07:30AM
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference Jun 7, 2022 07:30AM


Apr 18, 2022 04:01PM Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
Apr 18, 2022 04:01PM Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
Apr 13, 2022 05:39AM Crinetics Pharmaceuticals (CRNX) Prices 5.63M Share Offering at $22.22/sh
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering